Alaunos Therapeutics (TCRT) Research & Development (2011 - 2026)
Alaunos Therapeutics' Research & Development was $388,000 in Q2 2026, up 109.7% from $185,000 a year earlier but down 9.1% from the prior quarter.
Powered by 
Analysis
Alaunos Therapeutics (TCRT) Research & Development (2011 - 2026) Analysis & Trends
On a trailing twelve-month basis, Alaunos Therapeutics' Research & Development was $1.65 million through Jun 30, 2026, up 179.3% year-over-year; for FY2025, it was $1.36 million, up 276.5% from FY2024.
- Research & Development shows a five-year compound annual growth rate of -51.9% (FY2020 to FY2025).
- In earlier years, Research & Development was $362,000 in FY2024 (-97.8%), $16.28 million in FY2023 (-34.9%), $25.02 million in FY2022 (-49.6%) and $49.64 million in FY2021 (-5.8%).
- Quarterly Research & Development has moved between -$86,000 (Q4 2024) and $14.52 million (Q3 2021) over five years.
- Compared with a year earlier, Research & Development was higher in five of the last six quarters, with growth averaging 73.8%.
- The best year-over-year quarter for Research & Development over five years was Q3 2025 (growth of 228.0%); the worst was Q1 2024 (a decline of 98.1%).
- Per Business Quant data, TCRT's Research & Development in the three quarters before Q2 2026 was $427,000 (Q1 2026), $361,000 (Q4 2025) and $469,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Alaunos Therapeutics | 2.39 Mn | -1.41 Mn | - | 388,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 388,000.00 |
| Mar 31, 2026 | 427,000.00 |
| Dec 31, 2025 | 361,000.00 |
| Sep 30, 2025 | 469,000.00 |
| Jun 30, 2025 | 185,000.00 |
| Mar 31, 2025 | 347,000.00 |
| Dec 31, 2024 | -86,000.00 |
| Sep 30, 2024 | 143,000.00 |
| Jun 30, 2024 | 180,000.00 |
| Mar 31, 2024 | 126,000.00 |
| Dec 31, 2023 | 933,000.00 |
| Sep 30, 2023 | 3.66 Mn |
| Jun 30, 2023 | 5.19 Mn |
| Mar 31, 2023 | 6.50 Mn |
| Dec 31, 2022 | 5.61 Mn |
| Sep 30, 2022 | 7.89 Mn |
| Jun 30, 2022 | 5.94 Mn |
| Mar 31, 2022 | 5.58 Mn |
| Dec 31, 2021 | 8.22 Mn |
| Sep 30, 2021 | 14.52 Mn |
API Access
Alaunos Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=TCRT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "TCRT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=TCRT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();